SEC Form 4 · accession 0001185185-15-003350
U.S. Stem Cell, Inc. · USRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mike Tomas
Officer — CEO & President · Director
Period of report
Dec 11, 2015
Accepted (ET)
Dec 21, 2015 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 11, 2015 | C | 1,514 | — | A | 9,193 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1$0.6794 to $0.75